Bosh sahifaNG9 • FRA
add
NeoGenomics, Inc.
Yopilish kursi
7,55 €
Kunlik diapazon
7,35 € - 7,35 €
Yillik diapazon
4,20 € - 11,30 €
Bozor kapitalizatsiyasi
1,11 mlrd USD
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 190,17 mln | 10,56% |
Joriy xarajat | 95,82 mln | 3,53% |
Sof foyda | -9,88 mln | 35,52% |
Sof foyda marjasi | -5,20 | 41,64% |
Har bir ulushga tushum | 0,06 | 50,00% |
EBITDA | 3,91 mln | 35,35% |
Amaldagi soliq stavkasi | 20,35% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 159,62 mln | -58,74% |
Jami aktivlari | 1,36 mlrd | -16,98% |
Jami passivlari | 523,27 mln | -28,87% |
Umumiy kapital | 836,56 mln | — |
Tarqatilgan aksiyalar | 129,81 mln | — |
Narxi/balansdagi bahosi | 1,16 | — |
Aktivlardan daromad | -2,28% | — |
Kapitaldan daromad | -2,50% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -9,88 mln | 35,52% |
Operatsiyalardan naqd pul | 1,34 mln | -86,30% |
Sarmoyadan naqd pul | -6,30 mln | -15,33% |
Moliyadan naqd pul | 431,00 ming | -37,26% |
Naqd pulning sof oʻzgarishi | -4,50 mln | -189,62% |
Boʻsh pul | 618,38 ming | -80,33% |
Haqida
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia
Tashkil etilgan
2002
Sayt
Xodimlar soni
2 500
